A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia.

Trial Profile

A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Eszopiclone (Primary) ; Zolpidem
  • Indications Insomnia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 18 Jan 2012 Results were presented in an Eisai media release.
    • 30 Nov 2010 A Marketing Authorization Application has been submitted in Japan based on the results from this study.
    • 21 Sep 2010 Assumed completed; checked with ms1.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top